相似文献
1
Mutant metabolic enzymes are at the origin of gliomas.
Cancer Res. 2009 Dec 15;69(24):9157-9. doi: 10.1158/0008-5472.CAN-09-2650.
2
IDH1/2 gene hotspot mutations in central nervous system tumours: analysis of 922 Chinese patients.
Pathology. 2016 Dec;48(7):675-683. doi: 10.1016/j.pathol.2016.07.010. Epub 2016 Oct 22.
3
IDH1 and IDH2 mutations in gliomas.
N Engl J Med. 2009 Feb 19;360(8):765-73. doi: 10.1056/NEJMoa0808710.
4
Estimation of the occurrence rates of and mutations in gliomas and the reconsideration of -wildtype anaplastic astrocytomas: an institutional experience.
J Int Med Res. 2021 Jun;49(6):3000605211019258. doi: 10.1177/03000605211019258.
5
IDH mutation analysis in gliomas as a diagnostic and prognostic biomarker.
Br J Neurosurg. 2013 Aug;27(4):442-5. doi: 10.3109/02688697.2013.771139. Epub 2013 Mar 1.
6
IDH2 mutation in gliomas including novel mutation.
Neuropathology. 2015 Jun;35(3):236-44. doi: 10.1111/neup.12187. Epub 2014 Dec 12.
7
[Mutation of isocitrate dehydrogenase gene in Chinese patients with glioma].
Zhonghua Bing Li Xue Za Zhi. 2013 May;42(5):292-8. doi: 10.3760/cma.j.issn.0529-5807.2013.05.002.
8
IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain.
Biochem Biophys Res Commun. 2010 Jul 30;398(3):585-7. doi: 10.1016/j.bbrc.2010.06.125. Epub 2010 Jul 13.
9
IDH-mutant diffuse gliomas: tips and tricks in the era of genomic tumor classification.
Histol Histopathol. 2023 Jul;38(7):739-753. doi: 10.14670/HH-18-582. Epub 2023 Jan 9.
10
ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an "integrated" diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma.
Acta Neuropathol. 2015 Jan;129(1):133-46. doi: 10.1007/s00401-014-1370-3. Epub 2014 Nov 27.
引用本文的文献
1
Unraveling the signaling mechanism behind astrocytoma and possible therapeutics strategies: A comprehensive review.
Cancer Rep (Hoboken). 2023 Oct;6(10):e1889. doi: 10.1002/cnr2.1889. Epub 2023 Sep 7.
2
Regulative Roles of Metabolic Plasticity Caused by Mitochondrial Oxidative Phosphorylation and Glycolysis on the Initiation and Progression of Tumorigenesis.
Int J Mol Sci. 2023 Apr 11;24(8):7076. doi: 10.3390/ijms24087076.
3
Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas.
Molecules. 2023 Mar 23;28(7):2890. doi: 10.3390/molecules28072890.
4
Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign.
Cancers (Basel). 2023 Feb 7;15(4):1037. doi: 10.3390/cancers15041037.
5
Tau Protein as Therapeutic Target for Cancer? Focus on Glioblastoma.
Cancers (Basel). 2022 Nov 1;14(21):5386. doi: 10.3390/cancers14215386.
6
Multicentric Glioma: An Ideal Model to Reveal the Mechanism of Glioma.
Front Oncol. 2022 Jun 7;12:798018. doi: 10.3389/fonc.2022.798018. eCollection 2022.
7
Alterations in Molecular Profiles Affecting Glioblastoma Resistance to Radiochemotherapy: Where Does the Good Go?
Cancers (Basel). 2022 May 13;14(10):2416. doi: 10.3390/cancers14102416.
8
Distribution of copy number variations and rearrangement endpoints in human cancers with a review of literature.
Mutat Res. 2022 Jan-Jun;824:111773. doi: 10.1016/j.mrfmmm.2021.111773. Epub 2021 Dec 14.
9
D-2-Hydroxyglutarate in Glioma Biology.
Cells. 2021 Sep 7;10(9):2345. doi: 10.3390/cells10092345.
10
A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database.
Cancers (Basel). 2021 Aug 26;13(17):4299. doi: 10.3390/cancers13174299.
本文引用的文献
1
Recurring mutations found by sequencing an acute myeloid leukemia genome.
N Engl J Med. 2009 Sep 10;361(11):1058-66. doi: 10.1056/NEJMoa0903840. Epub 2009 Aug 5.
2
Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas.
J Clin Oncol. 2009 Sep 1;27(25):4150-4. doi: 10.1200/JCO.2009.21.9832. Epub 2009 Jul 27.
3
Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
Acta Neuropathol. 2009 Oct;118(4):469-74. doi: 10.1007/s00401-009-0561-9. Epub 2009 Jun 25.
4
Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
Acta Neuropathol. 2009 Sep;118(3):401-5. doi: 10.1007/s00401-009-0550-z. Epub 2009 Jun 19.
5
Understanding the Warburg effect: the metabolic requirements of cell proliferation.
Science. 2009 May 22;324(5930):1029-33. doi: 10.1126/science.1160809.
6
IDH1 and IDH2 mutations in gliomas.
N Engl J Med. 2009 May 21;360(21):2248; author reply 2249. doi: 10.1056/NEJMc090593.
7
IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas.
Neuro Oncol. 2009 Aug;11(4):341-7. doi: 10.1215/15228517-2009-025. Epub 2009 May 12.
8
Frequent IDH1 mutations in supratentorial primitive neuroectodermal tumors (sPNET) of adults but not children.
Cell Cycle. 2009 Jun 1;8(11):1806-7. doi: 10.4161/cc.8.11.8594. Epub 2009 Jun 30.
9
Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers.
Int J Cancer. 2009 Jul 15;125(2):353-5. doi: 10.1002/ijc.24379.
10
Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.
Science. 2009 Apr 10;324(5924):261-5. doi: 10.1126/science.1170944.
Zotero 插件